Connection

Hermes Florez to Glucagon-Like Peptides

This is a "connection" page, showing publications Hermes Florez has written about Glucagon-Like Peptides.
Connection Strength

0.331
  1. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet. 2019 07 13; 394(10193):131-138.
    View in: PubMed
    Score: 0.166
  2. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019 07 13; 394(10193):121-130.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.